Healthy habits are key to preventing the disease, cancer experts say
Patients whose disease has spread to bone can cut side effects tied to zoledronic acid, researchers report
New device has improved long-term quality of life for man who had larynx removed
A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical trial.
After undergoing treatment for early-stage breast cancer, many postmenopausal women take drugs known as aromatase inhibitors to reduce the risk of the cancer returning. These drugs, however, can cause significant pain in women’s joints and muscles.
Researchers credit declines in smoking, better detection and treatment
Patient recovery may mean longer time to the treatment, but study suggests it can still have benefit
Waiving costs appears to improve mammography rates, but not colonoscopy, even among the poor
The drug is approved for women whose cancers have progressed despite treatment with two or more chemotherapies and whose tumors have a mutation in the BRCA1 or BRCA2 genes, as identified by an FDA-approved companion diagnostic test. About 15% to 20% of ovarian cancers harbor a BRCA mutation.
As its concluding project, The Cancer Genome Atlas (TCGA) Research Network will complete the most comprehensive cross-cancer analysis to date: The Pan-Cancer Atlas (PanCanAtlas). This project aims to answer big, overarching questions about cancer by examining the full set of tumors characterized in the robust TCGA dataset.
Suggested sources of this beneficial vitamin